CXCL8 and familial pancreatic carcinoma: IL-8 has been studied as a prognostic marker in many cancer types [11], and high expression of IL-8 in the serum or plasma of cancer patients has been correlated with worse disease prognosis and poor survival, including in patients with breast [28], ovarian [29], and pancreatic cancer [30].